GlassScriptPhysician profile
Diana Perez
NPI 1295263903
$3,981.47
in general payments reported to CMS, 2019-2025
18 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $20.57 · 2021: $158 · 2022: $451 · 2023: $1,672 · 2024: $249 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,592 · Consulting Fee: $1,395 · Entertainment: $51.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,592.20 |
| Consulting Fee | $1,395.00 |
| Entertainment | $51.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,787.01 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $314.40 | 2022-2025 | Infuse |
| Dompe US, INC. | $243.83 | 2021-2025 | Oxervate |
| Biotissue Holdings INC. | $221.26 | 2022-2023 | |
| Glaukos Corporation | $203.45 | 2025 | Photrexa Viscous and Photrexa |
| Notal Vision, INC. | $201.12 | 2025 | Foresee Home |
| Coopervision INC. | $180.92 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Harrow Eye, LLC | $176.33 | 2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $147.41 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $146.67 | 2022 | |
| Genentech USA, INC. | $112.18 | 2019 | |
| Kala Pharmaceuticals, INC. | $82.47 | 2021-2022 | |
| Optos, INC. | $51.72 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $49.93 | 2024 | Cirrus Hd-Oct |
| Abbvie INC. | $22.20 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.57 | 2020 | |
| Sight Sciences, INC. | $20.00 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.